cannabis indica

Índice completo — página 27 de 77

Estudos 2.601 a 2.700 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2021. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 2.601 a 2.700

  1. 2021

    Roles of Cannabidiol in the treatment and prevention of Alzheimer's disease by multi-target actions

    FavorávelMetanáliseDoença de Alzheimer
  2. 2021

    Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoEndocanabinoide (não especificado)
  3. 2021

    Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis

    FavorávelEnsaio ClínicoEsclerose MúltiplaTHC FarmacêuticoTHC:CBD Farmacêutico+1
  4. 2021

    Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications

    FavorávelMetanáliseAutismo
  5. 2021

    Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review

    FavorávelMetanáliseFibromialgia
  6. 2021

    Safety and tolerability of escalating cannabinoid doses in healthy cats

  7. 2021

    Safety and tolerability of escalating cannabinoid doses in healthy cats

    FavorávelEstudo em AnimaisAplicações Veterinárias
  8. 2021

    Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years" accumulated evidence from clinical trials

    FavorávelMetanálise ClínicaDorDor — CrônicaDoenças NeurodegenerativasTHC:CBD Farmacêutico+6
  9. 2021

    Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports

  10. 2021

    Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

  11. 2021

    Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies

  12. 2021

    Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial

    FavorávelEnsaio ClínicoEpilepsiaEncefalite e Mielite
  13. 2021

    Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers

    DesfavorávelEnsaio Clínico Duplo-CegoAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)
  14. 2021

    Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience

    FavorávelMetanáliseEsclerose MúltiplaTHC:CBD Farmacêutico
  15. 2021

    Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association-The Example of Cannabis and Psychosis

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicose
  16. 2021

    Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS

    InconclusivoEstudo LaboratorialCanabinoide Sintético (não especificado)THC Farmacêutico+3
  17. 2021

    Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

  18. 2021

    Sedative effects of l-menthol, d-camphor, phenylethyl alcohol, and geraniol

    FavorávelEstudo em AnimaisAnsiedadeInsônia e Distúrbios do Sono
  19. 2021

    Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use

    DesfavorávelMetanáliseEpilepsia
  20. 2021

    Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol

  21. 2021

    Selective cannabis strain allergy in a patient presenting with a local allergic reaction

    DesfavorávelMetanáliseAlergia à Cannabis
  22. 2021

    Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates

  23. 2021

    Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV

    InconclusivoMetanáliseInflamaçãoHIV/AIDS
  24. 2021

    Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction

    FavorávelMetanáliseTDA e TDAH
  25. 2021

    Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada

    FavorávelMetanáliseDependência QuímicaDependência — Nicotina
  26. 2021

    Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaPsicose+2
  27. 2021

    Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity

    InconclusivoMetanáliseEsteatose HepáticaAnandamida (AEA)
  28. 2021

    Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia

    InconclusivoEstudo em AnimaisPsicoseEsquizofrenia
  29. 2021

    Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity

    FavorávelEnsaio ClínicoEsclerose MúltiplaTHC:CBD Farmacêutico
  30. 2021

    Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy

    FavorávelEstudo em AnimaisAlterações Cerebrais Neonatais
  31. 2021

    Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center

    FavorávelMetanáliseDorDor — Crônica
  32. 2021

    Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease

  33. 2021

    Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence

    DesfavorávelEnsaio ClínicoInsônia e Distúrbios do Sono
  34. 2021

    Social Anxiety, Cannabis Use Motives, and Social Context's Impact on Willingness to Use Cannabis

    InconclusivoEnsaio ClínicoAnsiedade
  35. 2021

    Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro

  36. 2021

    Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis

    InconclusivoMetanáliseDorDor — Crônica
  37. 2021

    Spinal astroglial cannabinoid receptors control pathological tremor

    FavorávelEstudo em AnimaisTremor EssencialCanabinoides Sintéticos WIN-x
  38. 2021

    Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators

    FavorávelEstudo em AnimaisEndocanabinoide (não especificado)
  39. 2021

    State Medical Marijuana Laws and Initiation of Cigarettes among Adolescents in the U.S., 1991-2015

    FavorávelMetanáliseDependência QuímicaDependência — Nicotina
  40. 2021

    State of the science: cannabis and cannabinoids in palliative medicine-the potential

    InconclusivoMetanáliseCuidados PaliativosTHC:CBD Farmacêutico
  41. 2021

    Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic review of case reports

    DesfavorávelMetanáliseAVC
  42. 2021

    Structural correlates of sensorimotor dysfunction in heavy cannabis users

  43. 2021

    Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies

    FavorávelEstudo LaboratorialCOVID-19
  44. 2021

    Substance use as a risk factor for bipolar disorder: A systematic review

  45. 2021

    Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+3
  46. 2021

    Substituting Cannabidiol for Opioids and Pain Medications Among Individuals with Fibromyalgia: a Large Online Survey

    FavorávelMetanáliseFibromialgia
  47. 2021

    Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?

  48. 2021

    Surveillance of work-related asthma including the emergence of a cannabis-associated case series in Washington State

    FavorávelMetanáliseEfeitos Adversos da CannabisAsma
  49. 2021

    Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms

    FavorávelMetanáliseDorAnsiedadeDor — CrônicaCanabigerol (CBG)+2
  50. 2021

    Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease

  51. 2021

    Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol

    FavorávelMetanáliseAutismo
  52. 2021

    Synergic Neuroprotection Between Ligusticum Chuanxiong Hort and Borneol Against Ischemic Stroke by Neurogenesis via Modulating Reactive Astrogliosis and Maintaining the Blood–Brain Barrier

    FavorávelEstudo em AnimaisAVC
  53. 2021

    Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  54. 2021

    Synthetic Cannabinoid-Related Deaths in England, 2012-2019

  55. 2021

    Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

  56. 2021

    Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors

  57. 2021

    Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre

  58. 2021

    Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use.

  59. 2021

    Systematic review of the impact of cannabinoids on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury

  60. 2021

    Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca2+ Homeostasis

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  61. 2021

    Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression

  62. 2021

    Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models

  63. 2021

    Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L

    FavorávelEstudo LaboratorialCOVID-19
  64. 2021

    Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

  65. 2021

    Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review

  66. 2021

    Targeting the endocannabinoid system with microbial interventions to improve gut integrity

  67. 2021

    Tea tree oil extract causes mitochondrial superoxide production and apoptosis as an anticancer agent, promoting tumor infiltrating neutrophils cytotoxic for breast cancer to induce tumor regression

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — MamaOutros Compostos Relacionados+7
  68. 2021

    Telephone veteran peer coaching for mental health treatment engagement among rural veterans: The importance of secondary outcomes and qualitative data in a randomized controlled trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+2
  69. 2021

    Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels

    DesfavorávelEstudo LaboratorialAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+6
  70. 2021

    Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats

    DesfavorávelEstudo em AnimaisDorDII — Doença Inflamatória Intestinal
  71. 2021

    Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

    FavorávelMetanáliseDorDor — CrônicaAVCTHC:CBD Farmacêutico+1
  72. 2021

    Tetrahydrocannabinol and Its Major Metabolites are Not (or are poor) Substrates or Inhibitors of Human P-glycoprotein (P-gp/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2)

    InconclusivoEstudo LaboratorialCâncerCâncer — Mama
  73. 2021

    THC and CBD effects on alcohol use among alcohol and cannabis co-users

    FavorávelMetanáliseDependência QuímicaDependência — Álcool
  74. 2021

    THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways

    InconclusivoEstudo em AnimaisAnsiedadeTEPT
  75. 2021

    THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults

    InconclusivoEnsaio ClínicoDisfunção CognitivaDPOC
  76. 2021

    THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

  77. 2021

    The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets

    FavorávelMetanáliseAnsiedadeEpilepsiaEsquizofrenia
  78. 2021

    The Activation of Cannabinoid Type-2 Receptor with JWH-133 Protects Uterine Ischemia/Reperfusion-Induced Damage

  79. 2021

    The acute and non-acute effects of cannabis on reward processing: A systematic review

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  80. 2021

    The Alerting and Orienting Systems of Attention Are Modified by Cannabis Dependence

  81. 2021

    The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination

    FavorávelEstudo em AnimaisInflamaçãoCanabigerol (CBG)
  82. 2021

    The antimicrobial effect behind Cannabis sativa

    FavorávelMetanáliseInfecções BacterianasAnandamida (AEA)Canabigerol (CBG)+6
  83. 2021

    The antimicrobial potential of cannabidiol

    FavorávelEstudo LaboratorialInfecções BacterianasInfecção por EstafilococosGonorreia
  84. 2021

    The antimicrobial potential of cannabidiol

    FavorávelEstudo LaboratorialInfecção por Estafilococos
  85. 2021

    The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder

  86. 2021

    The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  87. 2021

    The association between cannabis use disorder and the outcome following primary total hip arthroplasty : analysis of a nationwide administrative claims database

    DesfavorávelMetanáliseDependência QuímicaDependência — Cannabis
  88. 2021

    The association of cannabis use with quality of life and psychosocial functioning in psychosis

    DesfavorávelMetanálisePsicose
  89. 2021

    The associations between prenatal cannabis use disorder and neonatal outcomes

    DesfavorávelMetanáliseDependência QuímicaDependência — Cannabis
  90. 2021

    The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  91. 2021

    The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — Aguda
  92. 2021

    The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors

  93. 2021

    The cannabinoid system and microglia in health and disease

  94. 2021

    The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

  95. 2021

    The Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin, and 11-nor-9-carboxy-∆9-THC in Hair

    FavorávelEstudo LaboratorialCanabinol (CBN)Tetraidrocanabivarina (THCV)
  96. 2021

    The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice

    InconclusivoEstudo em AnimaisAnsiedadeDisfunção CognitivaTEPTCanabigerol (CBG)
  97. 2021

    The CB 1 Receptor Differentially Regulates IFN-γ Production In Vitro and in Experimental Autoimmune Encephalomyelitis

    FavorávelEstudo LaboratorialInflamaçãoEncefalite e MieliteEndocanabinoide (não especificado)
  98. 2021

    The concomitant use of cannabis and cocaine coexists with increased LPS levels and systemic inflammation in male drug users

    DesfavorávelEnsaio ClínicoDependência QuímicaInflamaçãoDependência — Cannabis+2
  99. 2021

    The Current and Potential Application of Medicinal Cannabis Products in Dentistry

  100. 2021

    The Differential Effect of Cannabidiol on the Composition and Physicochemical Properties of Keratinocyte and Fibroblast Membranes from Psoriatic Patients and Healthy People

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoPsoríase